Marco Muscianisi

Induction and Prolonged Induction With Mirikizumab in Ulcerative Colitis—A Prospective, Real‐World Study From the Sicilian Network for Inflammatory Bowel Disease (SN‐IBD)

Giuseppe Costantino, Anna Viola, Andrea Iuculano, Fabio Salvatore Macaluso et autres

it, ar, es (code pays fourni par la source)

ACNMD26-194: CLINICAL IMPROVEMENT WITH PARTIAL HISTOLOGIC RESPONSE TO TOFACITINIB IN EOSINOPHILIC ENTEROCOLITIS - A CASE REPORT

Laura Patanè, Giuseppe Blando, Lucrezia Laschi, Marco Muscianisi et autres

P1003 Effectiveness of Mirikizumab as induction therapy in ulcerative colitis -a prospective multicentre real-life study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

G Costantino, Anna Viola, A Iuculano, R Li Voti et autres

it, ar, es (code pays fourni par la source)

Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction

L. Patanè, Giuseppe Costantino, Marco Muscianisi, Clara De Francesco et autres

it (code pays fourni par la source)

Cardiovascular risk stratification in patients with inflammatory bowel disease: The role of non-invasive imaging techniques and traditional risk scores

Arianna Toscano, Giuseppe Blando, L. Patanè, Angela Messineo et autres

it (code pays fourni par la source)

Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative Colitis

Anna Viola, Raffaele Li Voti, Chiara Bivacqua, Clara De Francesco et autres

it (code pays fourni par la source)

Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center

Anna Viola, Maria Giulia Demarzo, Alfredo Abbruzzese, Marco Muscianisi et autres

it (code pays fourni par la source)

Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease

Irene Cacciola, Concetta Pitrone, Maria Stella Franzè, Carmelo Mazzeo et autres

it (code pays fourni par la source)

Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease

Federica Bellone, Alberto Sardella, Marco Muscianisi, Giorgio Basile

it (code pays fourni par la source)

P305 Effectiveness and Safety of Vedolizumab in Biologic-Naïve Patients: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

Fabio Salvatore Macaluso, Walter Fries, Sara Renna, Anna Viola et autres

it (code pays fourni par la source)

P439 Effectiveness of Ustekinumab on Crohn’s disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

Fabio Salvatore Macaluso, Walter Fries, Anna Viola, Giuseppe Costantino et autres

it (code pays fourni par la source)

Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

Anna Viola, Marco Muscianisi, Fabio Salvatore Macaluso, Marco Ventimiglia et autres

it (code pays fourni par la source)